PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the Department of Neurology (K.B., L.K., L.L., F.M.-C., N.C., J.S.), Hôpitaux Universitaires de Strasbourg; Clinical Investigation Center (K.B., L.K., N.C., J.S.), Hôpitaux Universitaires de Strasbourg; INSERM 1119 Biopathologie de la Myéline (K.B., L.K., N.C., J.S.), Neuroprotection et Stratégies Thérapeutiques; and Department of Public Health (T.F.), Hôpitaux Universitaires de Strasbourg, France. kevin.bigaut@chru-strasbourg.fr.\', \'From the Department of Neurology (K.B., L.K., L.L., F.M.-C., N.C., J.S.), Hôpitaux Universitaires de Strasbourg; Clinical Investigation Center (K.B., L.K., N.C., J.S.), Hôpitaux Universitaires de Strasbourg; INSERM 1119 Biopathologie de la Myéline (K.B., L.K., N.C., J.S.), Neuroprotection et Stratégies Thérapeutiques; and Department of Public Health (T.F.), Hôpitaux Universitaires de Strasbourg, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e105510.1212/NXI.0000000000001055
?:hasPublicationType
?:journal
  • Neurology(R) neuroimmunology & neuroinflammation
is ?:pmid of
?:pmid
?:pmid
  • 34321333
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti-SARS-CoV-2 Antibodies: An Observational Study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34321333>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34321333>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all